Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GL2-MY2095 | Mouse | Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (4D1) (MALS verified) |
|
|
|
| GL2-MY2094 | Mouse | Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (3E2) (MALS verified) |
|
|
Immobilized Rubella virus Glycoprotein E2 & E1 (strain M33) (RUBV), His Tag&Strep II Tag at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (3E2) (Cat. No. GL2-MY2094) with a linear range of 0.15-2.5 ng/mL (QC tested).
The purity of Monoclonal Anti-Rubella virus Glycoprotein E2 & E1 Antibody, Human IgG1 (4D1) (Cat. No. GL2-MY2095) is more than 90% and the molecular weight of this protein is around 135-160 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| MBL-HCV1 | MBL-HCV1 | Phase 2 Clinical | Massbiologics | Rejection of liver transplantation; Hepatitis C | Details |
This web search service is supported by Google Inc.
A-Z
